Clinical Trials Browser

Phase 1/2 × Urinary Bladder Neoplasms × Everolimus × Clear all

NCT01259063 2018-03-13

RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder

Phase 1/2 Completed

33 enrolled 11 charts

Urinary Bladder Neoplasms